Cordant Inc’s Amgen AMGN Stock Holding History

Cordant Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-76	Closed	-$18K	–	119
2022 Q1	$18K	Buy	+76	New	+$17.5K	0.01%	82
2020 Q1	–	Sell	-70	Closed	-$17K	–	64
2019 Q4	$17K	Buy	+70	New	+$15.4K	0.01%	59

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cordant Inc's AMGN Position: Q2 2022 in Review

Cordant Inc sold out of Amgen (AMGN) in Q2 2022, closing a stake of 76 shares — an estimated $18K sold.

Cordant Inc first reported a position in AMGN in Q4 2019 and held it in 2 quarters. The position peaked at $18K in Q1 2022. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

Cordant Inc reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 76 Amgen shares in Q2 2022, an estimated $18K.
Cordant Inc first reported a position in Amgen in Q4 2019 and held it in 2 quarters.
Cordant Inc's Amgen position peaked at $18K in Q1 2022.
2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.